IGNITION focuses on understanding and addressing anti-IgLON5 disease, a rare and complex neurological condition first identified in 2014 by members of the current consortium. Through an integrated programme combining innovative research, clinical expertise, and cross-sectoral training, IGNITION will equip a new generation of researchers to tackle the mechanisms underlying this disorder and related forms of neurodegeneration.
The meeting included Roberta Gentile's participation, the Project Officer from the Research Executive Agency (REA), who provided valuable guidance on project implementation and upcoming expectations within the framework of the Marie Skłodowska-Curie Actions. Also in attendance was Ava Easton, executive director of Encephalitis International, who was recently awarded an MBE (Member of the Order of the British Empire) by His Majesty the King in the New Year 2026 Honours List for her work and research in encephalitis.
Led by the Clínic-IDIBAPS, the IGNITION consortium brings together from 8 European countries, 13 associated partners spanning universities, research institutes, hospitals, SMEs, industry, a patient organisation, and a specialised training provider.
During the Kick-Off Meeting, partners reviewed the scientific Work Packages, training programme structure, communication activities, and management procedures. The event also enabled teams to strengthen collaboration ahead of the recruitment of the Doctoral Candidates who will join the project in the coming months.
With strong engagement across all institutions and a clear roadmap ahead, IGNITION is now well-positioned to advance its research and training goals and contribute to improving knowledge and future therapeutic strategies for autoimmune neurodegenerative diseases.
